NFE2L2 and Alzheimer disease: Hence, the interplay between Nrf2 activation and chronic OS suggests neuroprotective strategies using an association of compounds that can either activate the Nrf2 pathway by ROS independent mechanisms or act directly as ROS scavenger compounds that may thus be required to reduce OS in AD [12].